Cure for Anemia? Maybe!

  BIOTECH'S INFLUENCE ON CURES!

  •       These applications are still under development.

ROCHE'S DISCOVERY : CERA

"Results demonstrated a dose-dependent hemoglobin after 6 weeks of approximately 60% of patients had a dose response. HB levels maintained or improved during the 12 week period."



An anti-anemia drug that would compete with Amgen Inc.'s anemia treatment Aranesp -- is slated for launch in 2012, and it will have at least five others on the market by 2017, Merck

 RNA DISCOVERY: RNA ROCKS!

  • "Equine infectious anemia is shown to have an associated RNA-instructed DNA polymerase similar in its cofactor requirements and reaction conditions to the RNA tumor virus DNA polymerases. DNA polymerase activity requires a critical concentration of a nonionic detergent, all four deoxyribonucleoside triphosphates, and a divalent metal ion. The reaction is sensitive to RNase, and a substantial fraction of the FNA synthesized is complementary to viral RNA. The detection of a complex of tritium-labeled polymerase product DNA-template RNA, provided evidence that EIAV contains high-molecular-weight RNA. The results obtained with both virus propagated in cell culture and viruses from the serum of an experimentally infected horse; indicate that EIAV may properly be considered a member of the family Retroviridae. They may also be pertinent to the mechanism of viral persistence and periodic recrudescence of disease in chronically infected horses."
Make a Free Website with Yola.